BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27151488)

  • 1. Hydroxycut-related Vanishing Bile Duct Syndrome.
    Adike A; Smith ML; Chervenak A; Vargas HE
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):142-144. PubMed ID: 27151488
    [No Abstract]   [Full Text] [Related]  

  • 2. Lamotrigine-induced vanishing bile duct syndrome in a child.
    Bhayana H; Appasani S; Thapa BR; Das A; Singh K
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
    Bonkovsky HL; Kleiner DE; Gu J; Odin JA; Russo MW; Navarro VM; Fontana RJ; Ghabril MS; Barnhart H; Hoofnagle JH;
    Hepatology; 2017 Apr; 65(4):1267-1277. PubMed ID: 27981596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.
    Vuppalanchi R; Chalasani N; Saxena R
    Am J Surg Pathol; 2006 Dec; 30(12):1619-23. PubMed ID: 17122520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary and Pancreatic: Sertraline-induced vanishing bile duct syndrome treated with plasmapheresis.
    Tejedor-Tejada J; García-Pajares F; Madrigal Rubiales B
    J Gastroenterol Hepatol; 2019 Mar; 34(3):488. PubMed ID: 30536927
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of vanishing bile duct syndrome with hyperlipidemia.
    Yamauchi R; Takata K; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Nabeshima K; Yoshimitsu K; Hirai F
    Clin J Gastroenterol; 2022 Aug; 15(4):784-790. PubMed ID: 35802301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome.
    Yao F; Behling CA; Saab S; Li S; Hart M; Lyche KD
    Am J Gastroenterol; 1997 Jan; 92(1):167-9. PubMed ID: 8995964
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.
    Davies MH; Harrison RF; Elias E; Hübscher SG
    J Hepatol; 1994 Jan; 20(1):112-6. PubMed ID: 8201211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
    Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
    Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis.
    Kawasaki Y; Matsubara K; Hashimoto K; Tanigawa K; Kage M; Iwata A; Nigami H; Fukaya T
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):e30-1. PubMed ID: 23969539
    [No Abstract]   [Full Text] [Related]  

  • 14. Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse.
    Capra F; Nicolini N; Morana G; Guglielmi A; Capelli P; Vantini I
    Dig Dis Sci; 2005 Aug; 50(8):1535-7. PubMed ID: 16110850
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged cholestasis and ductopenia following gold salt therapy.
    Basset C; Vadrot J; Denis J; Poupon J; Zafrani ES
    Liver Int; 2003 Apr; 23(2):89-93. PubMed ID: 12654130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis].
    Yoon JY; Min SY; Park JY; Hong SG; Park SJ; Paik SY; Park YM
    Korean J Hepatol; 2008 Mar; 14(1):97-101. PubMed ID: 18367862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute vanishing bile duct syndrome after ibuprofen therapy in a child.
    Taghian M; Tran TA; Bresson-Hadni S; Menget A; Felix S; Jacquemin E
    J Pediatr; 2004 Aug; 145(2):273-6. PubMed ID: 15289784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced Bile Duct Injury - A Short Review.
    Dobreva I; Karagyozov P
    Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced bile duct injury.
    Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced bile duct injury: progress and challenges].
    Li DL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.